康复新联合喜疗妥在动静脉内瘘中的应用研究  

The Application Research of Kangfuxin Liquid Combined Hirudoid in Arteriovenous Fistula

作　　者：杨晗[1] 邓丽蓉[1] 王琴[1] 肖妍琴 

机构地区：[1]绵阳市中心医院血液净化中心,四川绵阳621000

出　　处：《四川医学》2014年第12期1578-1580,共3页Sichuan Medical Journal

摘　　要：目的观察康复新联合喜疗妥对促进动静脉内瘘穿刺术后皮下血肿吸收的疗效。方法对2012年10月至2014年5月在该院长期维持性血液透析中发生的出血面积>2cm2的皮下血肿90例次,按就诊顺序随机分为治疗组(喜疗妥加康复新组)和对照组(洗疗妥组),观察治疗24、48、72h后患者疼痛缓解、瘀斑及血肿消失情况,并进行统计学分析。结果治疗后48h内两组血肿消退差异无统计学意义(P>0.05);治疗后72h治疗组皮下血肿消退明显优于对照组,差异有统计学意义(P<0.05)。结论康复新联合喜疗妥能有效促进皮下血肿吸收,减轻患者症状。Objective To observe the efficacy of Kangfuxin Liquid combinedhirudoid in the treatment of puncture point bleeding and subcutaneoushematoma related to arteriovenous fistula after paracentesis. Methods 90 patients with puncture point bleeding patients and 90 patients with subcutaneoushematoma were randomly divided into treatment group（Kangfuxin Liquid com-binedhirudoid） and control group （hirudoid）,which were in ourhospital long-term maintenance hemodialysis in October 2012 to May 2014. The puncture point of bleeding and the pain relief and the situation of ecchymosis and hematoma were observed at 24, 48,72h after this treatment. Results The treatment group of the puncture point bleeding time is less than the control group obvi-ously（P 〈 0. 05）. The treatment group of the subcutaneoushematoma and the situation of ecchymosis were superior to the control group at 72h（P 〈 0. 05）. Conclusion Kangfuxin Liquid combinedhirudoid Can effectively shorten the puncture in patients with bleeding time and fadehematoma,relieve symptoms.

关 键 词：动静脉内瘘 穿刺点出血 皮下血肿 喜疗妥 康复新 

分 类 号：R473.5[医药卫生—护理学]